干细胞来源的生物起搏细胞的研究进展
被引量：2
Advances in stem cell-derived biological pacemaker cells
摘要
既往研究显示不同种属及多种类型的干细胞以某种方式干预可获得心肌样细胞,包括心室、心房和窦房结样细胞。众多研究更专注于获取心室肌样细胞,以改善心肌梗死后心脏功能。获取起搏细胞或结样细胞以构建生物起搏或研究新型抗心律失常药物等逐渐成为研究热点。本研究旨在综述干预胚胎干细胞、成人间充质干细胞和诱导多能干细胞获取生物起搏细胞的方法及展望未来研究的方向。
作者
赵红宜
黄从新
Zhao Hongyi;Huang Congxin
出处
《中华心律失常学杂志》
2020年第4期428-431,共4页
Chinese Journal of Cardiac Arrhythmias
二级参考文献15
-
1Hohnloser SH,Crijns HJ,van Eickels M,et al.Effect of dronedarone on cardiovascular events in atrial fibrillation.N Engl J Med,2009,360:668-678.
-
2Kφber L,Torp-Pedersen C,McMurray JJ,et al.Increased mortality after dronedarone therapy for severe heart failure.N Engl J Med,2008,358:2678-2687.
-
3Wazni OM,Marrouche NF,Martin DO,et al.Radiofrequency abla tion vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation:a randomized trial.JAMA,2005,293:2634-2640.
-
4Ja(I)s P,Cauchemez B,Macle L,et al.Catheter ablation versus anti arrhythmic drugs for atrial fibrillation:the A4 study.Circulation,2008,118:2498-2505.
-
5Hsu LF,Ja(I)s P,Sanders P,et al.Catheter ablation for atrial fibril lation in congestive heart failure.N Engl J Med,2004,351:2373-2383.
-
6Pappone C,Rosanio S,Augello G,et al.Mortality,morbidity,and quality of life after circumferential pulmonary vein ablation for atri al fibrillation:outcomes from a controlled nonrandomized long-term study.J Am Coll Cardiol,2003,42:185-197.
-
7Effect of enalapril on survival in patients with reduced left ventric ular ejection fractions and congestive heart failure.The SOLVD In vestigators.N Engl J Med,1991,325:293-302.
-
8Vermes E,Tardif JC,Bourassa MG,et al.Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dys function:insight from the Studies of Left Ventricular Dysfunction (SOLVD) trials.Circulation,2003,107:2926-2931.
-
9Maggioni AP,Anand I,Gottlieb SO,et al.Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.J Am Coll Cardiol,2002,40:1414-1421.
-
10Maggioni AP,Latini R,Carson PE,et al.Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:results from the Valsartan Heart Failure Trial (Val-HeFT).Am Heart J,2005,149:548-557.
同被引文献3
-
1任璐,褚延鹏,于善栋,吴林.多离子通道阻滞剂抗心律失常与致心律失常机制中晚钠电流的作用[J].中华心律失常学杂志,2016,20(2):160-163. 被引量：9
-
2尤欣宇,马静,尹清晟,王曼,张艳军,庄朋伟.基于实时细胞分析技术的乌头碱致心律失常体外评价技术研究[J].中国药理学通报,2019,35(12):1771-1775. 被引量：3
-
3刘蕾,马壮.肺动脉高压诊治指南解读[J].中国实用内科杂志,2020,40(5):377-381. 被引量：17
引证文献2
-
1尹琳,黄从新.分化抑制因子在心血管系统中的研究进展[J].中华心律失常学杂志,2021,25(3):270-273. 被引量：3
-
2陈兴,李小荣,谢欣,王学成,余金波,王嘉显,周秀娟,杨兵.基于实时细胞分析技术的人诱导多能干细胞源性心肌细胞的药物毒性评价研究[J].中华心律失常学杂志,2021,25(6):520-525.
二级引证文献3
-
1古联,梁一帆,杨怡冰,刘晶,曾文璐,申婷婷.分化抑制因子3作为缺血性脑卒中诊断标志物的研究及其与免疫浸润的关系[J].中国医药,2023,18(3):370-375. 被引量：1
-
2葛丽君,卢蔚波,简士凯,郑慧敏,薛静.EPA/DHA型磷脂酰胆碱对MPP+诱导的SH-SY5Y细胞损伤的保护作用[J].中国食品学报,2024,24(5):138-149. 被引量：1
-
3李鹏飞.尾加压素Ⅱ和嗜铬粒蛋白 A在慢性心力衰竭患儿血清中的表达及诊断意义[J].中国妇幼保健,2024,39(10):1802-1805.
